The weekly litigation news digest is live. Subscribe now

IP Verse

Method Of Treatment - EP2976101

The patent EP2976101 was granted to Glaxosmithkline on Aug 19, 2020. The application was filed on Mar 17, 2014 under application number EP14711232A. The patent is currently recorded with a legal status of "Revoked".

EP2976101

GLAXOSMITHKLINE
Application Number
EP14711232A
Filing Date
Mar 17, 2014
Status
Revoked
Feb 2, 2024
Publication Date
Aug 19, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
SANOFI PASTEURMay 18, 2021WILDINGADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONUS2008193476
EXAMINATIONUS2008305127
INTERNATIONAL-SEARCH-REPORTAU2012203419
OPPOSITIONWO2007000314
OPPOSITIONWO2007111940
OPPOSITIONWO9942130

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents